Edition:
United States

PLx Pharma Inc (PLXP.OQ)

PLXP.OQ on NASDAQ Stock Exchange Capital Market

4.35USD
18 May 2018
Change (% chg)

-- (--)
Prev Close
$4.35
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
3,707
52-wk High
$9.40
52-wk Low
$3.20

Chart for

About

PLx Pharma Inc., formerly Dipexium Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is a late stage specialty pharmaceutical company focusing on commercializing its lead products: Aspertec 325 mg and Aspertec 81 mg (Aspertec). The Company’s products and technology includes PLxGuard delivery system, Aspertec 325... (more)

Overall

Beta: 1.89
Market Cap(Mil.): $37.52
Shares Outstanding(Mil.): 8.73
Dividend: --
Yield (%): --

Financials

  PLXP.OQ Industry Sector
P/E (TTM): -- 237.88 32.90
EPS (TTM): -1.03 -- --
ROI: -46.90 -7.38 12.74
ROE: -74.43 -10.11 14.64

BRIEF-PLX Pharma Reports Q1 Earnings Per Share Of $0.57

* Q1 EARNINGS PER SHARE $0.57 Source text for Eikon: Further company coverage:

May 11 2018

BRIEF-PLx Pharma Q4 Loss Per Share $0.90

* Q4 REVENUE $340,000 Source text for Eikon: Further company coverage:

Mar 23 2018

Earnings vs. Estimates